ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $610,023 | -9.9% | 38,318 | -7.4% | 0.03% | -27.5% |
| Q3 2022 | $677,000 | -66.9% | 41,394 | -71.5% | 0.04% | -71.0% |
| Q2 2022 | $2,047,000 | -41.8% | 145,289 | 0.0% | 0.14% | -20.2% |
| Q1 2022 | $3,519,000 | -32.9% | 145,289 | -35.4% | 0.17% | -28.8% |
| Q4 2021 | $5,248,000 | +52.4% | 224,830 | +8.5% | 0.24% | +53.8% |
| Q3 2021 | $3,443,000 | +15.9% | 207,284 | +70.2% | 0.16% | +19.7% |
| Q2 2021 | $2,971,000 | +32.2% | 121,802 | +39.8% | 0.13% | +33.3% |
| Q1 2021 | $2,247,000 | +5.5% | 87,111 | +118.7% | 0.10% | -18.9% |
| Q4 2020 | $2,129,000 | – | 39,823 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |